The choice of systemic adjuvant therapy in receptor-positive early breast cancer
- 1 February 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (3) , 357-364
- https://doi.org/10.1016/j.ejca.2004.11.017
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast CancerJournal of Clinical Oncology, 2003
- Markers of increased risk for failure of adjuvant therapiesThe Breast, 2003
- Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Overhauling the breast cancer overview: are subsets subversive?The Lancet Oncology, 2002
- Influence of Endocrine-Related Factors on Response to Perioperative Chemotherapy for Patients With Node-Negative Breast CancerJournal of Clinical Oncology, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisThe Lancet, 2001
- Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsAnnals of Oncology, 2000
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsPublished by Elsevier ,2000
- Tumor Characteristics and Clinical Outcome of Elderly Women With Breast CancerJNCI Journal of the National Cancer Institute, 2000
- Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen ReceptorsJournal of Clinical Oncology, 2000